Gail Mkele
Gail Mkele publishes mostly in Endocrinology, Diabetes and Metabolism, Epidemiology and Oncology, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #7,490,935 of 7,710,434 ranked researchers
- Rank in United States
- #1,612,388 of 1,627,098
- Works
- 35
- Citations
- 49
- Citations per work
- 1.4
What does Gail Mkele research?
Gail Mkele's work is mostly in Medicine (46%), Economics, Econometrics and Finance (8%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1646.5%
- Medicine1646.5%
- Everything else1440.7%
- Social Sciences38.1%
- Life Sciences24.7%
- 1Endocrinology, Diabetes and Metabolism22% of their works
- 2Epidemiology9% of their works
- 3Oncology8% of their works
- 4Economics and Econometrics8% of their works
- 5Dermatology7% of their works
- 6Molecular Biology5% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes Management and Research
- Health Systems, Economic Evaluations, Quality of Life
- Menopause: Health Impacts and Treatments
- Neuroendocrine Tumor Research Advances
- Pharmaceutical Practices and Patient Outcomes
- Peptidase Inhibition and Analysis
- Bone health and treatments
Which keywords describe Gail Mkele's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cardiovascular Outcomes, Type 2 Diabetes, Cardiovascular Disease, Breast Cancer, Cost-effectiveness Analysis and Diabetes.
- Tumor Microenvironment
- Pancreatic Neuroendocrine Tumors
- Neuroendocrine Tumors
- Hormone Therapy
- Estrogen
- Quality of Life
- Diabetes
- Breast Cancer
- Type 2 Diabetes
- Insulin Therapy
- Glycemic Control
- Cardiovascular Outcomes
- Cardiovascular Disease
- Cost-effectiveness Analysis
- Hypoglycemia
- Bisphosphonates
- Fibroblast Activation Protein
- Inappropriate Medication Use
- Osteonecrosis of the Jaw
- Polypharmacy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Glycemic Control142 topics
- Insulin Therapy142 topics
- Cardiovascular Outcomes101 topic
- Type 2 Diabetes101 topic
- Cardiovascular Disease72 topics
- Breast Cancer62 topics
- Cost-effectiveness Analysis41 topic
- Diabetes41 topic
- Hypoglycemia41 topic
- Quality of Life41 topic
- Bisphosphonates31 topic
- Estrogen31 topic
- Fibroblast Activation Protein31 topic
- Hormone Therapy31 topic
- Inappropriate Medication Use31 topic
- Neuroendocrine Tumors31 topic
- Osteonecrosis of the Jaw31 topic
- Pancreatic Neuroendocrine Tumors31 topic
- Polypharmacy31 topic
- Tumor Microenvironment31 topic
Where does Gail Mkele work?
Gail Mkele's main affiliation in the publication record is Management Sciences for Health, United States.
How many publications and citations does Gail Mkele have?
OpenAlex counts 35 works and 49 citations for Gail Mkele, an h-index of 4, ranking #7,490,935 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gail Mkele. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.